Call for papers - Reproduction, Technology and Society, a new section in Reproductive BioMedicine Online
Page URL: https://www.bionews.org.uk/page_94380

Sperm test for infertile men could reduce need for surgery

25 November 2013
Appeared in BioNews 732

Researchers have developed a non-surgical test that could be used to tell whether men with zero sperm counts might be able to father children via IVF.

The study, led by a team from Toronto's Mount Sinai Hospital identifies two proteins in semen that can be used as biological markers to predict the likelihood of finding sperm though surgical investigation. Currently, testicular biopsy is the only diagnostic method to determine the specific cause of the infertility.

Non-obstructive infertility refers to the failure of sperm to develop properly. In this case retrieving sperm for use in IVF is very difficult, and often impossible. But when the cause is obstruction in a man’s reproductive system, sperm retrieval is much easier.

Study leader Professor Keith Jarvi told The Canadian Press his team was 'trying to eliminate unnecessary surgery for the patient'.

He added: 'You can avoid biopsies in many of the men. And I think for a lot of the men, they just want to know what their options are earlier on'.

The pair of proteins - ECM1 and TEX101 – were selected from 2,000 candidate biomarkers. Their predictive value was tested first in 30 patients, then on an additional 119. The researchers were able to distinguish obstructive from non-obstructive infertility every time, although the test could not be considered 100 percent accurate.

Study lead author Dr Andrei Drabovich told The Canadian Press that the team was working to draw on samples from other clinics to confirm the findings.

Speaking to BBC News, Dr Allan Pacey, senior lecturer in andrology at the University of Sheffield and chair of the British Fertility Society, said the study was 'very encouraging indeed'.

'Having an accurate biochemical test which might help doctors advise men whether taking a piece of the testicle is worth doing or not, would be very useful', he said.

'It could help men make better decisions, avoid unnecessary surgical procedures and potentially help save money by not having to do surgical procedures that aren't needed'.

Work is now underway to adapt the test for use in fertility clinics. 'Optimistically, it would be a year away, pessimistically, two years - we're moving along really quickly', Dr Jarvi told the BBC.

SOURCES & REFERENCES
Differential Diagnosis of Azoospermia with Proteomic Biomarkers ECM1 and TEX101 Quantified in Seminal Plasma
Science Translational Medicine |  20 November 2013
New test takes the sting out of sperm testing for infertile men
ABC News |  21 November 2013
Simple test could replace surgery to diagnose male infertility
Mount Sinai Hospital (press release) |  20 November 2013
Sperm test for infertile men could reduce surgery
BBC News |  21 November 2013
Toronto lab identifies proteins that could form basis of male infertility test
The Globe and Mail |  21 November 2013
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
14 December 2015 - by Ayala Ochert 
Men who have been diagnosed with infertility have a higher risk of developing heart disease and type 2 diabetes, as well as other general health problems, including alcohol abuse and drug abuse...
6 January 2014 - by Antony Starza-Allen 
The High Court of Australia has awarded damages under contract law to a doctor who purchased assets of a fertility clinic, including a stock of cryopreserved sperm, after almost two thirds of straws provided were unusable...
4 November 2013 - by Dr Naqash Raja 
A fertility test which allows men to check their sperm count in the comfort of their home - or wherever they feel is most suitable - has gone on sale in the UK...
12 August 2013 - by Dr Linda Wijlaars 
Sperm taken by biopsy from the testicles of men with a certain kinds of infertility can be cryopreserved without reducing the chances of a successful pregnancy...
13 June 2011 - by Kyrillos Georgiadis 
A new fertility test for men which can detect DNA damage in sperm has been developed in the UK. The test, called SpermComet, could save couples undergoing fertility treatment both time and money, since it will allow clinics to fast-track patients to the most appropriate treatment, say its developers...
24 May 2010 - by Dr Sophie Pryor 
German researchers have developed a new way of measuring the quality of human sperm cells by creating a chemical 'signature'...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.